Viewing Study NCT06943495


Ignite Creation Date: 2025-12-24 @ 1:57 PM
Ignite Modification Date: 2026-02-01 @ 7:02 PM
Study NCT ID: NCT06943495
Status: RECRUITING
Last Update Posted: 2025-09-09
First Post: 2025-03-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Personalized vs. Fixed-Activity 177Lu-PSMA-617 Radiopharmaceutical Therapy (PRODIGY-2)
Sponsor: Jean-Mathieu Beauregard
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Castrate Resistant Prostate Cancer (mCRPC) View
Keywords: